Feb 2026· Digital Health· Vol 12· 0 citations· 48 references
Medicine
TL;DR
A deep learning model based on whole slide images (WSIs) to predict post-treatment DM risk in patients with locally advanced NPC is developed and validated, demonstrating substantial discrimination, calibration, and clinical net benefit.
Abstract
Background Despite substantial therapeutic progress, distant metastasis (DM) persists as the leading cause of treatment failure and a critical driver of poor survival in nasopharyngeal carcinoma (NPC). Existing prognostic tools remain limited in accuracy and clinical utility, underscoring the need for more robust and actionable biomarkers. The convergence of artificial intelligence (AI) and digital pathology offers a promising avenue by enabling the extraction of prognostic signatures directly from routinely available histopathology. In this study, we developed and validated a deep learning (DL) model based on whole slide images (WSIs) to predict post-treatment DM risk in patients with locally advanced NPC. Methods We developed the Pathology-based distant metastasis risk stratification model (P-MES) using WSIs from 147 NPC patients. WSIs were encoded into patch-level embeddings using the pretrained UNI feature extractor, followed by multiple instance learning (MIL) aggregation to generate slide-level representations for predicting DM. To enhance interpretability, attention-based heatmaps were generated, and complementary morphologic features extracted by CellProfiler were used to elucidate histopathologic patterns associated with metastatic risk. Results P-MES achieved excellent predictive performance in the training, validation, and internal test sets (AUCs: 0.990, 0.887, and 0.949), demonstrating substantial discrimination, calibration, and clinical net benefit. CellProfiler analysis further identified ten morphology-derived features associated with DM. Conclusion P-MES is an automated, pathology-based framework for predicting DM in NPC, providing pathological insights and supporting personalized clinical management.
Background/Objectives: Adult-type diffuse gliomas (ADGs) are aggressive brain tumors with highly variable clinical outcomes. Prognostic assessment directly from routine hematoxylin and eosin (H&E)-stained whole-slide images (WSIs) could support personalized decision-making. Methods: To our knowledge, this is the first...
S. Innani, Carla Pitarch-Abaigar, Marwan M. Majeed et al.· Cancers· 0 citations
PURPOSE
Pretreatment estimation of pathological complete response (pCR) to neoadjuvant chemotherapy may support risk stratification and future response-adapted clinical studies in breast cancer. However, existing deep learning approaches often rely on "black-box" visual pattern recognition, suffering from poor interpre...
Background Surgical resection is the standard treatment for stage I lung adenocarcinoma, in most cases without additional systemic adjuvant treatment. A substantial proportion of stage I cases recur, with a 5-year survival rate <50%. Clinical data suggest that adjuvant treatment, including immune checkpoint inhibitor t...
O. Kilim, O. Pipek, Z. Sztupinszki et al.· Immuno-Oncology Technology· 0 citations
It is suggested that deep learning models, particularly Inception V3, can effectively predict TMB status in patients using histopathological images, and the potential for integrating DL techniques in clinical settings to enhance personalized treatment strategies for patients with varying TMB is highlighted.
T. A. Serel, Onur Ertunç, M. Kıran et al.· OBM Genetics· 0 citations
Hepatocellular carcinoma (HCC) is one of the most common and lethal malignancies, whose prognostic prediction is particularly challenging. Histopathological biomarkers are critical for cancer prognosis assessment. Advancements in artificial intelligence (AI) have made it possible to automate the classification and...
Deng-Bin Wu, Jiao-Yue Zhang, Mian Shi et al.· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.